Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1978 Nov;71(11):809–818. doi: 10.1177/014107687807101108

Hypothesis into theory--the development of aetiological concepts of ischaemic heart disease: a review.

B Lewis
PMCID: PMC1436187  PMID: 215767

Full text

PDF
810

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M. L. Evidence of regression of atherosclerosis in primates and man. Postgrad Med J. 1976 Jul;52(609):456–461. doi: 10.1136/pgmj.52.609.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armstrong M. L., Megan M. B. Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets. Circ Res. 1972 Jun;30(6):675–680. doi: 10.1161/01.res.30.6.675. [DOI] [PubMed] [Google Scholar]
  3. Avogaro P., Cazzolato G. Familial hyper-HDL-(a)-cholesterolemia. Atherosclerosis. 1975 Jul-Aug;22(1):63–77. doi: 10.1016/0021-9150(75)90068-4. [DOI] [PubMed] [Google Scholar]
  4. BARCLAY M., BARCLAY R. K., SKIPSKI V. P. HIGH-DENSITY LIPOPROTEIN CONCENTRATIONS IN MEN AND WOMEN. Nature. 1963 Oct 26;200:362–363. doi: 10.1038/200362b0. [DOI] [PubMed] [Google Scholar]
  5. BARR D. P., RUSS E. M., EDER H. A. Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am J Med. 1951 Oct;11(4):480–493. doi: 10.1016/0002-9343(51)90183-0. [DOI] [PubMed] [Google Scholar]
  6. Balogh M., Kahn H. A., Medalie J. H. Random repeat 24-hour dietary recalls. Am J Clin Nutr. 1971 Mar;24(3):304–310. doi: 10.1093/ajcn/24.3.304. [DOI] [PubMed] [Google Scholar]
  7. Barndt R., Jr, Blankenhorn D. H., Crawford D. W., Brooks S. H. Regression and progression of early femoral atherosclerosis in treated hyperlipoproteinemic patients. Ann Intern Med. 1977 Feb;86(2):139–146. doi: 10.7326/0003-4819-86-2-139. [DOI] [PubMed] [Google Scholar]
  8. Belfrage P., Berg B., Hägerstrand I., Nilsson-Ehle P., Tornqvist H., Wiebe T. Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur J Clin Invest. 1977 Apr;7(2):127–131. doi: 10.1111/j.1365-2362.1977.tb01584.x. [DOI] [PubMed] [Google Scholar]
  9. Benditt E. P., Benditt J. M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973 Jun;70(6):1753–1756. doi: 10.1073/pnas.70.6.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Benditt E. P. Implications of the monoclonal character of human atherosclerotic plaques. Am J Pathol. 1977 Mar;86(3):693–702. [PMC free article] [PubMed] [Google Scholar]
  11. Berg K., Borresen A. L. Serum-high-density-lipoprotein and atherosclerotic heart-disease. Lancet. 1976 Mar 6;1(7958):499–501. doi: 10.1016/s0140-6736(76)90291-9. [DOI] [PubMed] [Google Scholar]
  12. Berglund G., Sannerstedt R., Andersson O., Wedel H., Wilhelmsen L., Hansson L., Sivertsson R., Wikstrand J. Coronary heart-disease after treatment of hypertension. Lancet. 1978 Jan 7;1(8054):1–5. doi: 10.1016/s0140-6736(78)90356-2. [DOI] [PubMed] [Google Scholar]
  13. Bierman E. L., Albers J. J. Lipoprotein uptake by cultured human arterial smooth muscle cells. Biochim Biophys Acta. 1975 May 22;388(2):198–202. doi: 10.1016/0005-2760(75)90124-1. [DOI] [PubMed] [Google Scholar]
  14. Blackburn H. Concepts and controversies about the prevention of coronary heart disease. Postgrad Med J. 1976 Jul;52(609):417–423. doi: 10.1136/pgmj.52.609.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Brown M. S., Goldstein J. L. Receptor-mediated control of cholesterol metabolism. Science. 1976 Jan 16;191(4223):150–154. doi: 10.1126/science.174194. [DOI] [PubMed] [Google Scholar]
  16. Brunzell J. D., Schrott H. G., Motulsky A. G., Bierman E. L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism. 1976 Mar;25(3):313–320. doi: 10.1016/0026-0495(76)90089-5. [DOI] [PubMed] [Google Scholar]
  17. Carew T. E., Koschinsky T., Hayes S. B., Steinberg D. A mechanism by which high-density lipoproteins may slow the atherogenic process. Lancet. 1976 Jun 19;1(7973):1315–1317. doi: 10.1016/s0140-6736(76)92650-7. [DOI] [PubMed] [Google Scholar]
  18. Carlson L. A., Böttiger L. E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet. 1972 Apr 22;1(7756):865–868. doi: 10.1016/s0140-6736(72)90738-6. [DOI] [PubMed] [Google Scholar]
  19. Carlson L. A., Danielson M., Ekberg I., Klintemar B., Rosenhamer G. Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. Atherosclerosis. 1977 Sep;28(1):81–86. doi: 10.1016/0021-9150(77)90201-5. [DOI] [PubMed] [Google Scholar]
  20. Carlson L. A., Ekelund L. G., Olsson A. G. Frequency of ischaemic exercise E.C.G. Changes in symptom-free men with various forms of primary hyperlipaemia. Lancet. 1975 Jul 5;2(7923):1–3. doi: 10.1016/s0140-6736(75)92948-7. [DOI] [PubMed] [Google Scholar]
  21. Carlson L. A., Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction. Atherosclerosis. 1975 May-Jun;21(3):435–450. doi: 10.1016/0021-9150(75)90055-6. [DOI] [PubMed] [Google Scholar]
  22. Carter C. O., Slack J., Myant N. B. Genetics of hyperlipoproteinaemias. Lancet. 1971 Feb 20;1(7695):400–401. doi: 10.1016/s0140-6736(71)92238-0. [DOI] [PubMed] [Google Scholar]
  23. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet. 1977 Jul 23;2(8030):153–155. doi: 10.1016/s0140-6736(77)90176-3. [DOI] [PubMed] [Google Scholar]
  24. Chait A., Mancini M., February A. W., Lewis B. Clinical and metabolic study of alcoholic hyperlipidaemia. Lancet. 1972 Jul 8;2(7767):62–64. doi: 10.1016/s0140-6736(72)91552-8. [DOI] [PubMed] [Google Scholar]
  25. Chait A., Onitiri A., Nicoll A., Rabaya E., Davies J., Lewis B. Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition. Atherosclerosis. 1974 Sep-Oct;20(2):347–364. doi: 10.1016/0021-9150(74)90017-3. [DOI] [PubMed] [Google Scholar]
  26. Chen R. M., Getz G. S., Fischer-Dzoga K., Wissler R. W. The role of hyperlipidemic serum on the proliferation and necrosis of aortic medial cells in vitro. Exp Mol Pathol. 1977 Jun;26(3):359–374. doi: 10.1016/0014-4800(77)90039-9. [DOI] [PubMed] [Google Scholar]
  27. Diet-heart era: premature obituary? N Engl J Med. 1978 Jan 12;298(2):106–110. doi: 10.1056/NEJM197801122980214. [DOI] [PubMed] [Google Scholar]
  28. Doll R., Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J. 1976 Dec 25;2(6051):1525–1536. doi: 10.1136/bmj.2.6051.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Dorr A. E., Gundersen K., Schneider J. C., Jr, Spencer T. W., Martin W. B. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. J Chronic Dis. 1978 Jan;31(1):5–14. doi: 10.1016/0021-9681(78)90076-0. [DOI] [PubMed] [Google Scholar]
  30. Easty D. L. The relationship of diet to serum cholesterol levels in young men in Antarctica. Br J Nutr. 1970 Mar;24(1):307–312. doi: 10.1079/bjn19700030. [DOI] [PubMed] [Google Scholar]
  31. Epstein F. H. Genetics of ischaemic heart disease. Postgrad Med J. 1976 Aug;52(610):477–480. doi: 10.1136/pgmj.52.610.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Epstein F. H. Risk factors in coronary heart disease--environmental and hereditary influences. Isr J Med Sci. 1967 Jul-Aug;3(4):594–607. [PubMed] [Google Scholar]
  33. Feinleib M. Discussion of: "Epidemiology of cardiovascular diseases: current perspectives". Am J Epidemiol. 1976 Oct;104(4):457–462. doi: 10.1093/oxfordjournals.aje.a112316. [DOI] [PubMed] [Google Scholar]
  34. Fredrickson D. S. It's time to be practical. Circulation. 1975 Feb;51(2):209–211. doi: 10.1161/01.cir.51.2.209. [DOI] [PubMed] [Google Scholar]
  35. Fredrickson D. S. It's time to be practical. Circulation. 1975 Feb;51(2):209–211. doi: 10.1161/01.cir.51.2.209. [DOI] [PubMed] [Google Scholar]
  36. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 26;276(4):215–contd. doi: 10.1056/NEJM196701262760406. [DOI] [PubMed] [Google Scholar]
  37. Fredrickson D. S., Levy R. I., Lindgren F. T. A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest. 1969 Nov;47(11):2446–2457. doi: 10.1172/JCI105927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Førde O. H., Thelle D. S., Miller N. E., Mjøs O. D. The Tromsø heart study. Distribution of serum cholesterol between high density and lower density lipoproteins in subjects of Norse, Finnish and Lappish ethnic origin. Acta Med Scand. 1978;203(1-2):21–26. [PubMed] [Google Scholar]
  39. Glomset J. A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed] [Google Scholar]
  40. Goldstein J. L., Schrott H. G., Hazzard W. R., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest. 1973 Jul;52(7):1544–1568. doi: 10.1172/JCI107332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann Intern Med. 1977 Oct;87(4):393–397. doi: 10.7326/0003-4819-87-4-393. [DOI] [PubMed] [Google Scholar]
  42. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  43. Gordon T., Thom T. The recent decrease in CHD mortality. Prev Med. 1975 Jun;4(2):115–125. doi: 10.1016/0091-7435(75)90077-8. [DOI] [PubMed] [Google Scholar]
  44. Goto Y., Sato S. I., Masuda M. Causes of death in 3151 diabetic autopsy cases. Tohoku J Exp Med. 1974 Apr;112(4):339–353. doi: 10.1620/tjem.112.339. [DOI] [PubMed] [Google Scholar]
  45. Grundy S. M. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. J Clin Invest. 1975 Feb;55(2):269–282. doi: 10.1172/JCI107930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hammond E. C., Garfinkel L. Coronary heart disease, stroke, and aortic aneurysm. Arch Environ Health. 1969 Aug;19(2):167–182. [PubMed] [Google Scholar]
  47. Hazzard W. R., Goldstein J. L., Schrott M. G., Motulsky A. G., Bierman E. L. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J Clin Invest. 1973 Jul;52(7):1569–1577. doi: 10.1172/JCI107333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Heady J. A. Letter: Are PUFA harmful? Br Med J. 1974 Jan 19;1(5898):115–116. doi: 10.1136/bmj.1.5898.115-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Hickey N., Mulcahy R., Bourke G. J., Graham I., Wilson-Davis K. Study of coronary risk factors related to physical activity in 15 171 men. Br Med J. 1975 Aug 30;3(5982):507–509. doi: 10.1136/bmj.3.5982.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Jenkins D. J., Newton C., Leeds A. R., Cummings J. H. Effect of pectin, guar gum, and wheat fibre on serum-cholesterol. Lancet. 1975 May 17;1(7916):1116–1117. doi: 10.1016/s0140-6736(75)92503-9. [DOI] [PubMed] [Google Scholar]
  51. Johnson B., Bye C., Labrooy J., Munro-Faure D., Slack J. Proceedings: The relation of antihypertensive treatment to plasma lipids and other vascular risk factors in hypertensives. Clin Sci Mol Med. 1974 Aug;47(2):9P–10P. doi: 10.1042/cs047009pa. [DOI] [PubMed] [Google Scholar]
  52. Keen H. Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention. Postgrad Med J. 1976 Jul;52(609):445–451. doi: 10.1136/pgmj.52.609.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kritchevsky D. Experimental atherosclerosis in primates and other species. Ann N Y Acad Sci. 1969 Jul 3;162(1):80–88. doi: 10.1111/j.1749-6632.1969.tb56351.x. [DOI] [PubMed] [Google Scholar]
  54. Kushwaha R. S., Hazzard W. R., Wahl P. W., Hoover J. J. Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay. Ann Intern Med. 1977 Nov;87(5):509–516. doi: 10.7326/0003-4819-87-5-509. [DOI] [PubMed] [Google Scholar]
  55. Lewis B., Chait A., Oakley C. M., Wootton I. D., Krikler D. M., Onitiri A., Sigurdsson G., February A. Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J. 1974 Aug 24;3(5929):489–493. doi: 10.1136/bmj.3.5929.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Lewis B., Chait A., Sigurdsson G. Serum lipoprotiens in four European communities: a quantitative comparison. Eur J Clin Invest. 1978 Jun;8(3):165–173. doi: 10.1111/j.1365-2362.1978.tb00830.x. [DOI] [PubMed] [Google Scholar]
  57. Lewis B., Chait A., Wootton I. D., Oakley C. M., Krikler D. M., Sigurdsson G., February A., Maurer B., Birkhead J. Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet. 1974 Feb 2;1(7849):141–146. doi: 10.1016/s0140-6736(74)92438-6. [DOI] [PubMed] [Google Scholar]
  58. Mann G. V. Diet-Heart: end of an era. N Engl J Med. 1977 Sep 22;297(12):644–650. doi: 10.1056/NEJM197709222971206. [DOI] [PubMed] [Google Scholar]
  59. McMichael J. Dietetic factors in coronary disease. Eur J Cardiol. 1977 Aug;5(6):447–452. [PubMed] [Google Scholar]
  60. Miettinen M., Turpeinen O., Karvonen M. J., Elosuo R., Paavilainen E. Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet. 1972 Oct 21;2(7782):835–838. doi: 10.1016/s0140-6736(72)92208-8. [DOI] [PubMed] [Google Scholar]
  61. Miettinen T. A., Lempinen M. Cholestyramine and ileal by-pass in the treatment of familial hypercholesterolaemia. Eur J Clin Invest. 1977 Dec;7(6):509–514. doi: 10.1111/j.1365-2362.1977.tb01644.x. [DOI] [PubMed] [Google Scholar]
  62. Miller K. L. Post delivery care of the edentulous geriatric patient. Bull Phila Cty Dent Soc. 1975 Summer;40(8):16–19. [PubMed] [Google Scholar]
  63. Miller N. E., Nestel P. J., Clifton-Bligh P. Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. Atherosclerosis. 1976 May-Jun;23(3):535–547. doi: 10.1016/0021-9150(76)90013-7. [DOI] [PubMed] [Google Scholar]
  64. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  65. Moutafis C. D., Myant N. B. The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine. Clin Sci. 1969 Oct;37(2):443–454. [PubMed] [Google Scholar]
  66. Nikkilä E. A., Aro A. Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet. 1973 May 5;1(7810):954–959. doi: 10.1016/s0140-6736(73)91598-5. [DOI] [PubMed] [Google Scholar]
  67. Olefsky J., Reaven G. M., Farquhar J. W. Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest. 1974 Jan;53(1):64–76. doi: 10.1172/JCI107560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Oliver M. F., Nimmo I. A., Cooke M., Carlson L. A., Olsson A. G. Ischaemic heart disease and associated risk factors in 40 year old men in Edinburgh and Stockholm. Eur J Clin Invest. 1975 Nov 21;5(6):507–514. doi: 10.1111/j.1365-2362.1975.tb00483.x. [DOI] [PubMed] [Google Scholar]
  69. Onongbu I. C., Lewis B. Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta. 1976 Sep 20;71(3):397–402. doi: 10.1016/0009-8981(76)90090-5. [DOI] [PubMed] [Google Scholar]
  70. Pelkonen R., Nikkilä E. A., Koskinen S., Penttinen K., Sarna S. Association of serum lipids and obesity with cardiovascular mortality. Br Med J. 1977 Nov 5;2(6096):1185–1187. doi: 10.1136/bmj.2.6096.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Pikkarainen J., Takkunen J., Kulonen E. Serum cholesterol in Finnish twins. Am J Hum Genet. 1966 Mar;18(2):115–126. [PMC free article] [PubMed] [Google Scholar]
  72. ROWSELL H. C., DOWNIE H. G., MUSTARD J. F. The experimental production of atherosclerosis in swine following the feeding of butter and margarine. Can Med Assoc J. 1958 Oct 15;79(8):647–654. [PMC free article] [PubMed] [Google Scholar]
  73. Rinzler S. H. Primary prevention of coronary heart disease by diet. Bull N Y Acad Med. 1968 Aug;44(8):936–949. [PMC free article] [PubMed] [Google Scholar]
  74. Rissanen A. M., Nikkilä E. A. Coronary artery disease and its risk factors in families of young men with angina pectoris and in controls. Br Heart J. 1977 Aug;39(8):875–883. doi: 10.1136/hrt.39.8.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Roberts W. C., Ferrans V. J., Levy R. I., Fredrickson D. S. Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. Am J Cardiol. 1973 May;31(5):557–570. doi: 10.1016/0002-9149(73)90323-8. [DOI] [PubMed] [Google Scholar]
  76. Rose G. Detection of high coronary risk. Postgrad Med J. 1976 Jul;52(609):452–455. doi: 10.1136/pgmj.52.609.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Ross R., Glomset J., Harker L. Response to injury and atherogenesis. Am J Pathol. 1977 Mar;86(3):675–684. [PMC free article] [PubMed] [Google Scholar]
  78. Rutherford R. B., Ross R. Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol. 1976 Apr;69(1):196–203. doi: 10.1083/jcb.69.1.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Schrott H. G., Goldstein J. L., Hazzard W. R., McGoodwin M. M., Motulsky A. G. Familial hypercholesterolemia in a large indred. Evidence for a monogenic mechanism. Ann Intern Med. 1972 May;76(5):711–720. doi: 10.7326/0003-4819-76-5-711. [DOI] [PubMed] [Google Scholar]
  80. Shaper A. G. Primary and secondary prevention trials in coronary heart disease. Postgrad Med J. 1976 Jul;52(609):464–469. doi: 10.1136/pgmj.52.609.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet. 1969 Dec 27;2(7635):1380–1382. doi: 10.1016/s0140-6736(69)90930-1. [DOI] [PubMed] [Google Scholar]
  82. Sommariva D., Scotti L., Fasoli A. Low-fat diet versus low-carbohydrate diet in the treatment of type IV hyperlipoproteinaemia. Atherosclerosis. 1978 Jan;29(1):43–51. doi: 10.1016/0021-9150(78)90092-8. [DOI] [PubMed] [Google Scholar]
  83. Stone N. J., Levy R. I., Fredrickson D. S., Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974 Mar;49(3):476–488. doi: 10.1161/01.cir.49.3.476. [DOI] [PubMed] [Google Scholar]
  84. Sturdevant R. A., Pearce M. L., Dayton S. Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. N Engl J Med. 1973 Jan 4;288(1):24–27. doi: 10.1056/NEJM197301042880106. [DOI] [PubMed] [Google Scholar]
  85. Truswell A. S. Dietary fat and heart-disease. Lancet. 1977 Dec 3;2(8049):1173–1173. doi: 10.1016/s0140-6736(77)91557-4. [DOI] [PubMed] [Google Scholar]
  86. Walker W. J. Changing United States life-style and declining vascular mortality: cause or coincidence? N Engl J Med. 1977 Jul 21;297(3):163–165. doi: 10.1056/NEJM197707212970311. [DOI] [PubMed] [Google Scholar]
  87. West R. J., Fosbrooke A. S., Lloyd J. K. Treatment of children with familial hypercholesterolaemia. Postgrad Med J. 1975;51(8):82–87. [PubMed] [Google Scholar]
  88. Wilhelmsen L., Wedel H., Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation. 1973 Nov;48(5):950–958. doi: 10.1161/01.cir.48.5.950. [DOI] [PubMed] [Google Scholar]
  89. Wilson D. E., Lees R. S. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J Clin Invest. 1972 May;51(5):1051–1057. doi: 10.1172/JCI106896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Wood P. D., Haskell W., Klein H., Lewis S., Stern M. P., Farquhar J. W. The distribution of plasma lipoproteins in middle-aged male runners. Metabolism. 1976 Nov;25(11):1249–1257. doi: 10.1016/s0026-0495(76)80008-x. [DOI] [PubMed] [Google Scholar]
  91. Zilversmit D. B. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res. 1973 Dec;33(6):633–638. doi: 10.1161/01.res.33.6.633. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES